<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00341016</url>
  </required_header>
  <id_info>
    <org_study_id>999996030</org_study_id>
    <secondary_id>OH96-C-N030</secondary_id>
    <nct_id>NCT00341016</nct_id>
    <nct_alias>NCT00558974</nct_alias>
    <nct_alias>NCT01338233</nct_alias>
  </id_info>
  <brief_title>Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident</brief_title>
  <official_title>Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      Leukemia holds a special place in the study of radiation-related cancer because bone marrow
      is one of the tissues most sensitive to the carcinogenic effect of ionizing radiation,
      radiogenic leukemia has the shortest latent period among radiation-induced cancers, and its
      appearance suggests that solid tumors may follow. These same characteristics also contribute
      to its considerable significance in radiation protection. There are, nevertheless, important
      gaps in existing knowledge of radiation-induced leukemia, gaps that derive from
      characteristics of the study of the atomic bombing of Hiroshima and Nagasaki, and from
      studies of the effects of medical irradiation and studies of nuclear workers, these being the
      studies that have provided most of the information to date. These gaps include the presumed
      reduction in risk resulting from dose-fractionation and low dose-rate, and the time-response
      function in the first five years after exposure.

      The primary objective of this study is to investigate leukemia risk as a function of such
      radiation; it would constitute the largest epidemiologic study conducted to date among
      working-age males, a group of particular concern in establishing occupational radiation
      safety standards. In addition, data on cases of multiple myeloma and myelodysplasia
      identified in the cohort will be collected to test the hypothesis of a dose related
      association between radiation and increased risk for each of these diseases.

      The primary scientific objectives of the proposed study are to test the following hypotheses:
      (a) that there is a dose-related increase in risk of leukemia among these liquidators; (b)
      that the magnitude of any observed risk per unit dose is less than that seen in the atomic
      bomb survivors, exposed to essentially instantaneous radiation.

      Subsidiary objectives include: (a) to investigate the nature of the dose-response
      relationship among liquidators and to identify modifiers of risk, including time since
      exposure, age at exposure, etc.; (b) to test the hypothesis that there is a dose-related
      increased risk of multiple myeloma; (c) to test the hypothesis that there is a dose-related
      increased risk of myelodysplasial; (d) to collect and store buccal cells from about 2,000
      liquidators with a wide range of dose estimates extending to well over 1 Gy for possible use
      in future molecular studies of their DNA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Leukemia holds a special place in the study of radiation-related cancer because bone marrow
      is one of the tissues most sensitive to the carcinogenic effect of ionizing radiation.
      Radiogenic leukemia has the shortest latent period among radiation-induced cancers, and its
      appearance suggests that solid tumors may follow. These same characteristics also contribute
      to its considerable significance in radiation protection. There are, nevertheless, important
      gaps in existing knowledge of radiation-induced leukemia, gaps that derive from
      characteristics of the study of the atomic bombing of Hiroshima and Nagasaki, and from
      studies of the effects of medical irradiation and studies of nuclear workers; these are the
      studies that have provided most of the information to date. The gaps include the presumed
      reduction in risk resulting from dose-fractionation and low dose-rate, as well as the time-
      response function in the first five years after exposure. The study described herein is
      intended to fill those gaps.

      The Chornobyl accident exposed hundreds of thousands of people to radiation, notably those
      involved in its cleanup operations. The second phase of a case-control study of ionizing
      radiation and leukemia is being conducted in a cohort of approximately 100,000 Ukrainian
      &quot;liquidators&quot; involved in cleanup work following the accident at the Chornobyl Nuclear Power
      Plant in northern Ukraine which occurred on April 26, 1986. The cohort is restricted to
      liquidators who first worked around the power plant between 1986 and 1990 and were residents,
      when first registered in the Chornobyl State Registry, in Kyiv City or in one of five oblasts
      (major civil divisions) that comprise the study area. This cohort, consisting of males of
      working age, received mean bone marrow doses of approximately 80-100 milli-gray (mGy) at low
      to moderate dose rates, with those sent earlier receiving the highest doses. The primary
      objective of this study is to investigate leukemia risk as a function of such radiation; it
      constitutes probably the largest epidemiologic study conducted to date among working-age
      males, a group of particular concern in establishing occupational radiation safety standards.

      The primary scientific objectives of the proposed study are to evaluate whether there is a
      doserelated increase in risk of leukemia among these liquidators, and how it compares with
      the observed risk per unit dose seen in the atomic bomb survivors, exposed to essentially
      instantaneous radiation. A secondary objective is to identify any modifiers of risk,
      including time since exposure, age at exposure, etc.

      The field work for the second phase of the study, with an extended case ascertainment for
      2001 through 2006 has been complated. As a result of the second phase, a total of75 confirmed
      cases of leukemia and 12 cases of multiple myeloma have been ascertained. We are currently in
      the process of database construction, dosimetric calculation for data analyses for leukemia,
      and manuscript preparation.

      The small sub-study on uncertainties associated with human factors is to be started upon
      SSIRB approval.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 26, 1996</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The primary objective of this study is to investigate leukemia risk as a function of radiation ionizing radiation from occupational exposure (Chernobyl nuclear power plant)</measure>
    <time_frame>time of interview</time_frame>
    <description>Estimated risk of leukemia related to radiation exposure</description>
  </primary_outcome>
  <enrollment type="Actual">1779</enrollment>
  <condition>Leukemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Ukrainian Chernobyl cleanup workers (&quot;liquidators&quot;) approx. 100,000 persons
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:

        We intend to include in the proposed study all 350 clean-up workers with &quot;historical&quot;
        records and 150 proxies to be identified by the liquidators; however, we anticipate a
        considerable number of them will not be available for the study due to deaths, not being
        able to be traced, no response, refusals, etc. The study subjects will be interviewed in
        person. All study subjects are males, median age of early liquidators is 64 y while for
        clean-up workers sent to mission is about 61 years.

        EXCLUSION CRITERIA:

        Excluded from the study will be those who have been found to be deceased, cannot be
        located, refuse to participate in the study, or do not provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kiyohiko Mabuchi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Institute (NCI)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Center for Radiation Medicine</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ukraine</country>
  </location_countries>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <reference>
    <citation>Gudzenko N, Hatch M, Bazyka D, Dyagil I, Reiss RF, Brenner A, Chumak V, Babkina N, Zablotska LB, Mabuchi K. Non-radiation risk factors for leukemia: A case-control study among chornobyl cleanup workers in Ukraine. Environ Res. 2015 Oct;142:72-6. doi: 10.1016/j.envres.2015.06.019. Epub 2015 Jun 24.</citation>
    <PMID>26117815</PMID>
  </reference>
  <reference>
    <citation>Chumak VV, Romanenko AY, Voillequ√© PG, Bakhanova EV, Gudzenko N, Hatch M, Zablotska LB, Golovanov IA, Luckyanov NK, Sholom SV, Kryuchkov VP, Bouville A. The Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: II. Estimation of bone marrow doses. Radiat Res. 2008 Dec;170(6):698-710. doi: 10.1667/RR1403.1.</citation>
    <PMID>19138037</PMID>
  </reference>
  <reference>
    <citation>Zablotska LB, Bazyka D, Lubin JH, Gudzenko N, Little MP, Hatch M, Finch S, Dyagil I, Reiss RF, Chumak VV, Bouville A, Drozdovitch V, Kryuchkov VP, Golovanov I, Bakhanova E, Babkina N, Lubarets T, Bebeshko V, Romanenko A, Mabuchi K. Radiation and the risk of chronic lymphocytic and other leukemias among chornobyl cleanup workers. Environ Health Perspect. 2013 Jan;121(1):59-65. doi: 10.1289/ehp.1204996. Epub 2012 Nov 8.</citation>
    <PMID>23149165</PMID>
  </reference>
  <verification_date>February 23, 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2006</study_first_submitted>
  <study_first_submitted_qc>June 19, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2006</study_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <keyword>Radiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Hematologic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

